Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer Therapy

The high potential for therapeutic application of siRNAs to silence traditionally undruggable oncogenic drivers remains largely untapped due to the challenges of tumor cell delivery. Here, siRNAs were optimized for in situ binding to albumin through C(18) lipid modifications to improve pharmacokinet...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogenboezem, Ella N., Patel, Shrusti S., Cavnar, Ashley B., Lo, Justin H., Babb, Lauren M., Francini, Nora, Patil, Prarthana, Colazo, Juan M., Michell, Danielle L., Sanchez, Violeta M., McCune, Joshua T., Ma, Jinqi, DeJulius, Carlisle R., Lee, Linus H., Rosch, Jonah C., Allen, Ryan M., Stokes, Larry D., Hill, Jordan L., Vickers, Kasey C., Cook, Rebecca S., Duvall, Craig L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948981/
https://www.ncbi.nlm.nih.gov/pubmed/36824780
http://dx.doi.org/10.1101/2023.02.14.528574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948981/
https://www.ncbi.nlm.nih.gov/pubmed/36824780
http://dx.doi.org/10.1101/2023.02.14.528574

Ejemplares similares